Preeclampsia with Severe Features

Obstetrics & Gynecology

Illness script · Obstetrics & Gynecology

Preeclampsia with Severe Features

Hypertensive disorder of pregnancy ≥20 weeks with end-organ damage (BP ≥160/110, proteinuria ± severe features).

This illness script for Preeclampsia with Severe Features covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.

Updated Jul 19, 2026All scripts

01

Predisposing factors

  • Nulliparity is the strongest risk factor
  • Chronic hypertension, diabetes, renal disease, obesity
  • Prior preeclampsia (recurrence risk ~15–20%)
  • Multiple gestation, molar pregnancy
  • Age <18 or >35; African American race; autoimmune disease (SLE, antiphospholipid syndrome)

02

Presentation

  • BP ≥160/110 on two readings ≥4 hours apart after 20 weeks
  • Severe headache (frontal), visual changes (scotomata, blurring), RUQ/epigastric pain
  • Pulmonary edema, new-onset seizure (eclampsia), altered mental status
  • Thrombocytopenia (<100k), elevated LFTs (≥2× normal), rising creatinine (>1.1)
  • Fetal growth restriction on exam; hyperreflexia with clonus on neuro exam
  • Onset can be remote from term (early-onset <34 wks = more severe disease)

03

Pathophysiology

  • Abnormal placentation → shallow trophoblast invasion → inadequate spiral artery remodeling
  • Uteroplacental ischemia → systemic endothelial dysfunction and vasospasm
  • Vasoconstriction → hypertension, proteinuria (glomerular endotheliosis), end-organ ischemia
  • Imbalance: ↑ antiangiogenic sFlt-1, ↓ proangiogenic VEGF/PlGF

04

Diagnostics

  • BP ≥160/110 (severe threshold) + any severe feature = diagnosis
  • Proteinuria ≥300 mg/24h or PCr ≥0.3 (not required if severe features present)
  • CBC: thrombocytopenia; CMP: elevated creatinine, LFTs; LDH elevated
  • HELLP syndrome: Hemolysis + Elevated LFTs + Low Platelets — a severe feature variant
  • Fetal monitoring: NST, BPP, Doppler; no single biomarker is gold standard clinically

05

Management

  • Definitive treatment: delivery (only cure); timing depends on gestational age
  • ≥37 weeks (or ≥34 weeks with severe features): deliver promptly
  • <34 weeks: consider corticosteroids for fetal lung maturity then deliver
  • Acute BP control: IV labetalol or IV hydralazine or oral nifedipine (target <160/110 urgently)
  • Seizure prophylaxis: IV/IM magnesium sulfate (also first-line treatment for eclampsia)
  • Magnesium toxicity antidote: calcium gluconate; avoid MgSO4 in myasthenia gravis

06

Clinical pivots

How to separate this script from the look-alikes that show up on exams and on the wards.

  • Chronic Hypertension with Superimposed Preeclampsia

    Pre-existing HTN before 20 weeks; superimposed = acute end-organ damage added on top

  • Gestational Hypertension

    BP ≥140/90 after 20 weeks but NO proteinuria and NO severe features

  • HELLP Syndrome

    Hemolysis + elevated LFTs + low platelets; may present without severe hypertension or headache

  • Eclampsia

    New-onset grand mal seizure in preeclampsia patient; treat with MgSO4 not antiepileptics

View full library

Educational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.